UB Paderborn / Katalog / Suche / in CDI

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study

Annals of oncology, 2019-05, Vol.30 (5), p.845-852

2019

Volltextzugriff (PDF)

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis

British journal of cancer, 2004-01, Vol.90 (1), p.189-193

2004

Volltextzugriff (PDF)

5005 ORAL Exploratory Subgroup Analysis of the TAMRAD Phase 2 GINECO Trial Comparing Tamoxifen (TAM) Plus Everolimus (RAD) With TAM Alone in Patients With Hormone-receptor-positive, HER2-negative Metastatic Breast Cancer (mBC) With Prior Exposure to Aromatase Inhibitors (Als): Implication for Research Strategies

European journal of cancer (1990), 2011, Vol.47, p.S331-S331

2011

Volltextzugriff (PDF)

Dynamic adsorption on activated carbons of SO2 traces in air. I. Adsorption capacities

Carbon (New York), 2002, Vol.40 (12), p.2235-2246

2002

Volltextzugriff (PDF)

304P ESR1 mutations and outcomes in BRCA1/2 or PALB2 germline mutation carriers receiving first line aromatase inhibitor + palbociclib (AI+P) for metastatic breast cancer (MBC) in the PADA-1 trial

Annals of oncology, 2020-09, Vol.31, p.S364-S364

2020

Volltextzugriff (PDF)

Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1

BMJ open, 2022-03, Vol.12 (3), p.e055821-e055821

2022

Volltextzugriff (PDF)

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO)

Annals of oncology, 2012-02, Vol.23 (2), p.346-352

2012

Volltextzugriff (PDF)

Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study

Aging (Albany, NY.), 2015-12, Vol.7 (12), p.1066-1074

2015

Volltextzugriff (PDF)

Long term quality of life among epithelial ovarian cancer patients: The GINECO case/control VIVROVAIRE Study

Annals of oncology, 2017-09, Vol.28, p.v334-v334

2017

Volltextzugriff (PDF)

Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

Annals of oncology, 2001-07, Vol.12 (7), p.909-918

2001

Volltextzugriff (PDF)

Dynamic adsorption on activated carbons of SO2 traces in air

Carbon (New York), 2002, Vol.40 (12), p.2235-2246

2002

Volltextzugriff (PDF)

Benefit of a High-Dose Epirubicin Regimen in Adjuvant Chemotherapy for Node-Positive Breast Cancer Patients With Poor Prognostic Factors: 5-Year Follow-Up Results of French Adjuvant Study Group 05 Randomized Trial

Journal of clinical oncology, 2001-02, Vol.19 (3), p.602-611

By the French Adjuvant Study Group

2001

Volltextzugriff (PDF)

Kierkegaard : dépérissement du langage, parole du sujet

Revue de métaphysique et de morale (Paris, France : 1945), 2000-04, Vol.105 (2), p.163-177

Delecroix, V.

2000

Volltextzugriff (PDF)

Abstract OT3-3-04: ALOPREV: first cooling scalp trial for prevention of persisting alopecia after docetaxel for early breast cancer patients

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.OT3-3-04-OT3-3-04

2012

Volltextzugriff (PDF)

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study

Annals of oncology, 2019-05, Vol.30 (5), p.845

2019

Volltextzugriff (PDF)

A multicenter phase II trial of weekly paclitaxel (wPC) and epirubicin (E) in first line metastatic breast cancer (MBC) and pronostic impact of VEGF level

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.6122

2009

Volltextzugriff (PDF)

Long Term Persistent Alopecia and Suboptimal Hair Regrowth after Adjuvant Chemotherapy for Breast Cancer: Alert for an Emerging Side Effect: ALOPERS Observatory

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.3174-3174

2009

Volltextzugriff (PDF)

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3115-3124

the French Epirubicin Study Group

2000

Volltextzugriff (PDF)

Kierkegaard : dépérissement du langage, parole du sujet : Subjectivité et langage

Revue de métaphysique et de morale (Paris, France : 1945), 2000 (2), p.163-177

DELECROIX, V

2000

Volltextzugriff (PDF)

Dynamic adsorption on activated carbons of SO 2 traces in air : I. Adsorption capacities

Carbon (New York), 2002, Vol.40 (12), p.2235-2246

2002

Volltextzugriff (PDF)

Docetaxel combined with vinorelbine: phase I results and new study designs

Oncology (Williston Park, N.Y.), 1997-06, Vol.11 (6 Suppl 6), p.29

1997

Volltextzugriff (PDF)

359 Phase Ib and pharmacokinetic studies of Everolimus (RAD001), a novel oral mTOR-inhibitor, with paclitaxel in patients with advanced solid tumors

European journal of cancer supplements, 2004-09, Vol.2 (8), p.108-108

2004

Volltextzugriff (PDF)

New Systemic Therapy for Breast Cancer

Breast cancer (Tokyo, Japan), 1999-10, Vol.6 (4), p.382-385

1999

Volltextzugriff (PDF)

Anthracycline as second line chemotherapy (CT) for metastatic breast cancer (MBC) patients previously treated with taxotere (TXT)

European journal of cancer (1990), 1997-09, Vol.33, p.S150-S150

1997

Volltextzugriff (PDF)

970 An evaluation of the neurotoxicity of a phase I dose finding study of docetaxel (D) in combination with vinorelbin (V)

European journal of cancer (1990), 1995-11, Vol.31, p.S202-S202

1995

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis

Dynamic adsorption on activated carbons of SO2 traces in air. I. Adsorption capacities

304P ESR1 mutations and outcomes in BRCA1/2 or PALB2 germline mutation carriers receiving first line aromatase inhibitor + palbociclib (AI+P) for metastatic breast cancer (MBC) in the PADA-1 trial

Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO)

Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study

Long term quality of life among epithelial ovarian cancer patients: The GINECO case/control VIVROVAIRE Study

Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

Dynamic adsorption on activated carbons of SO2 traces in air

Benefit of a High-Dose Epirubicin Regimen in Adjuvant Chemotherapy for Node-Positive Breast Cancer Patients With Poor Prognostic Factors: 5-Year Follow-Up Results of French Adjuvant Study Group 05 Randomized Trial

Kierkegaard : dépérissement du langage, parole du sujet

Abstract OT3-3-04: ALOPREV: first cooling scalp trial for prevention of persisting alopecia after docetaxel for early breast cancer patients

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study

A multicenter phase II trial of weekly paclitaxel (wPC) and epirubicin (E) in first line metastatic breast cancer (MBC) and pronostic impact of VEGF level

Long Term Persistent Alopecia and Suboptimal Hair Regrowth after Adjuvant Chemotherapy for Breast Cancer: Alert for an Emerging Side Effect: ALOPERS Observatory

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Kierkegaard : dépérissement du langage, parole du sujet : Subjectivité et langage

Dynamic adsorption on activated carbons of SO 2 traces in air : I. Adsorption capacities

Docetaxel combined with vinorelbine: phase I results and new study designs

359 Phase Ib and pharmacokinetic studies of Everolimus (RAD001), a novel oral mTOR-inhibitor, with paclitaxel in patients with advanced solid tumors

New Systemic Therapy for Breast Cancer

Anthracycline as second line chemotherapy (CT) for metastatic breast cancer (MBC) patients previously treated with taxotere (TXT)

970 An evaluation of the neurotoxicity of a phase I dose finding study of docetaxel (D) in combination with vinorelbin (V)

Suchergebnisse filtern